A structure-based tool to interpret the significance of kinase mutations in clinical next generation sequencing in cancer一种基于结构的方法,用于解释癌症临床下一代测序中激酶突变的意义Frontiers in OncologyIF3.32025-08-050OA
Combinations of the azaquinazoline anti-Wolbachia agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasisFRONTIERS IN MICROBIOLOGYIF4.52024-02-012OAAI
Mutations in a-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases (vol 18, 29, 2023)MOLECULAR NEURODEGENERATIONIF17.52023-05-300OAAI
Mutations in α-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteasesMOLECULAR NEURODEGENERATIONIF17.52023-05-028OAAI
Fighting Plasmodium chloroquine resistance with acetylenic chloroquine analoguesINTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCEIF3.42022-12-013OAAI
Pyrvinium Pamoate and Structural Analogs Are Early Macrofilaricide LeadsPHARMACEUTICALSIF4.82022-02-023OAAI
Comparative Performance of Latest-Generation and FDA-Cleared Serology Tests for the Diagnosis of Chagas DiseaseJOURNAL OF CLINICAL MICROBIOLOGYIF5.42021-05-1920OA
The Eagle effect in the Wolbachia-worm symbiosisWolbachia-蠕虫共生中的鹰效应PARASITES & VECTORSIF3.52021-02-245OAAI
Short-course quinazoline drug treatments are effective in the Litomosoides sigmodontis and Brugia pahangi jird modelsINTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCEIF3.42020-04-0110OAAI
Chagas Disease Serological Test Performance in US Blood Donor SpecimensJOURNAL OF CLINICAL MICROBIOLOGYIF5.42019-12-0152OAAI